2J. A. Guy,Marie Shea,C. P. Peter,R. Morrissey,W. C. Hayed. Continuous alendronate treatment throughout growth, maturation, and aging in the rat results in increases in bone mass and mechanical properties[J] 1993,Calcified Tissue International(4):283～288
3Prof. S. Adami,M. C. Baroni,M. Broggini,L. Carratelli,I. Caruso,L. Gnessi,M. Laurenzi,A. Lombardi,G. Norbiato,S. Ortolani,E. Ricerca,L. Romanini,S. Subrizi,J. Weinberg,A. J. Yates. Treatment of postmenopausal osteoporosis with continuous daily oral alendronate in comparison with either placebo or intranasal salmon calcitonin[J] 1993,Osteoporosis International(3):21～27
4D. M. Black PhD,T. R Reiss,M. C. Nevitt,J. Cauley,D. Karpf,S. R. Cummings. Design of the Fracture Intervention Trial[J] 1993,Osteoporosis International(3):29～39
5H. Fleisch MD. New bisphosphonates in osteoporosis[J] 1993,Osteoporosis International(2):15～22
1Robert S. Weinstein,A. Michael Parfitt,Robert Marcus,Maria Greenwald,Gerald Crans,Douglas B. Muchmore. Effects of raloxifene, hormone replacement therapy, and placebo on bone turnover in postmenopausal women[J] 2003,Osteoporosis International(10):814～822
2Alfred A. Reszka MD,Gideon A. Rodan MD. Bisphosphonate mechanism of action[J] 2003,Current Rheumatology Reports(1):65～74
